BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7525912)

  • 1. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas.
    Terpe HJ; Koopmann R; Imhof BA; Günthert U
    J Pathol; 1994 Oct; 174(2):89-100. PubMed ID: 7525912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis.
    Ristamäki R; Joensuu H; Söderström KO; Jalkanen S
    J Pathol; 1995 Jul; 176(3):259-67. PubMed ID: 7545748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of integrin and CD44 adhesion molecules on neuroblastoma: the relation to tumor aggressiveness and embryonic neural-crest differentiation.
    Combaret V; Coll JL; Favrot MC
    Invasion Metastasis; 1994-1995; 14(1-6):156-63. PubMed ID: 7544774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
    Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New CD44 splice variants associated with human breast cancers.
    Iida N; Bourguignon LY
    J Cell Physiol; 1995 Jan; 162(1):127-33. PubMed ID: 7529235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
    Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
    Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
    Fox SB; Fawcett J; Jackson DG; Collins I; Gatter KC; Harris AL; Gearing A; Simmons DL
    Cancer Res; 1994 Aug; 54(16):4539-46. PubMed ID: 7519124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Occurrence of CD44 and its isoforms under orthological and pathological conditions].
    Terpe A; Franke F; Stark H; Gustmann C; Mackay C; Marston W; Günthert U
    Verh Dtsch Ges Pathol; 1993; 77():276-81. PubMed ID: 7511297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 splice variants: expression during lymphocyte activation and tumor progression.
    Pals ST; Koopman G; Heider KH; Griffioen A; Adolf GR; Van den Berg F; Ponta H; Herrlich P; Horst E
    Behring Inst Mitt; 1993 Aug; (92):273-7. PubMed ID: 7504454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.
    Rall CJ; Rustgi AK
    Cancer Res; 1995 May; 55(9):1831-5. PubMed ID: 7537174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
    Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
    Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
    Chaudhry A; Gobl A; Eriksson B; Skogseid B; Oberg K
    Cancer Res; 1994 Feb; 54(4):981-6. PubMed ID: 7508823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
    Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
    Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
    Gross N; Beretta C; Peruisseau G; Jackson D; Simmons D; Beck D
    Cancer Res; 1994 Aug; 54(15):4238-42. PubMed ID: 7518353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
    Harn HJ; Lee HS; Ho LI; Lee WH; Ding JH
    Biochem Mol Biol Int; 1994 Jul; 33(4):743-9. PubMed ID: 7526922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are CD44 variant isoforms involved in human tumour progression?
    Günthert U; Stauder R; Mayer B; Terpe HJ; Finke L; Friedrichs K
    Cancer Surv; 1995; 24():19-42. PubMed ID: 7553660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues.
    Terpe HJ; Stark H; Prehm P; Günthert U
    Histochemistry; 1994 Feb; 101(2):79-89. PubMed ID: 7520892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
    Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
    Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
    Stauder R; Eisterer W; Thaler J; Günthert U
    Blood; 1995 May; 85(10):2885-99. PubMed ID: 7537983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.